FDA PUBLIC HEARING on May 31, 2019

The Food and Drug Administration (FDA, the Agency, or
we) is announcing a public hearing to obtain scientific data and information about the safety, manufacturing, product
quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds. 

This hearing is an important step in determining the future regulation of hemp and its products.  Those in the hemp and hemp-derived CBD industries will have the opportunity to present their positions.  Many are eagerly anticipating the chance to weigh in.  While this meeting holds no guarantees about future changes, it is encouraging to see a Federal Agency coming to the table for open discussion with the members of an industry that they are seeking to regulate.

Anyone wishing to attend via free webinar can register by clicking the link below:  https://www.eventbrite.com/e/fda-public-hearing-scientific-data-and-info-about-cannabis-products-registration-60077969825

The full notice issued by the Office of the Federal Register is below:

FDA hearing notice PDF for website